Back
Kura Oncology 10K Form
Buy
65
KURA
Kura Oncology
Last Price:
19.49
Seasonality Move:
12.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KURA News And Ratings
See the #1 stock for the next 7 days that we like better than KURA
KURA Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-34.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.34 |
| Price / Book: | 3.64 |
Profitability
| EPS (TTM): | -2.08000 |
|---|---|
| Net Income (TTM): | $-152.63M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Kura Oncology Earnings Forecast
Key Kura Oncology Financial Ratios
- The Interest Expense is -1.01% of Operating Income.
- Per Share Earnings over the last 9 years have been positive in 2 years.
Kura Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KURA |
| CUSIP: | 50127T |
| Website: | kuraoncology.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KURA Technical Analysis vs Fundamental Analysis
Buy
65
Kura Oncology (KURA)
is a Buy
Is Kura Oncology a Buy or a Sell?
-
Kura Oncology stock is rated a Buy
The current Kura Oncology [KURA] share price is $19.00. The Score for KURA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.